FIELD: medicine. SUBSTANCE: method involves using N - nitro - L - arginine - L - NNA, N - nitro - L - argininemethylester - L - NANE as nitrogen oxide inhibitors administered at a dose of 1.0 ml of 27 mM solution gradually reducing the dose to 0.1-0.2 ml. Dinitrosyl complexes of iron with low molecular weight ligands like glutathione and cystein, S-nitroso thiols administered at a dose of beginning from 0.1-0.2 ml of 5.4 mM solution with its gradually increasing to 1.0 ml. EFFECT: stable therapeutic result. 3 cl
